Annual report pursuant to Section 13 and 15(d)

Note 12 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.8.0.1
Note 12 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 25,164,004 $ 20,523,640
Operating income (loss) (3,174,898) (15,007,976)
Depreciation and amortization:    
Depreciation and amortization 2,017,323 2,566,136
Operating income (loss) (3,174,898) (15,007,976)
Other expense, net (64,455) (1,467)
Loss before income tax expense (3,239,353) (15,009,443)
Operating Segments [Member]    
Operating income (loss) 4,539,000 (5,169,000)
Depreciation and amortization:    
Operating income (loss) 4,539,000 (5,169,000)
Corporate, Non-Segment [Member]    
Operating income (loss) (7,714,000) (9,839,000)
Depreciation and amortization:    
Operating income (loss) (7,714,000) (9,839,000)
Corporate Clinics [Member]    
Revenues 11,125,000 8,550,000
Operating income (loss) (1,704,000) (9,730,000)
Depreciation and amortization:    
Depreciation and amortization 1,608,000 2,186,000
Operating income (loss) (1,704,000) (9,730,000)
Franchise Operations [Member]    
Revenues 14,039,000 11,974,000
Operating income (loss) 6,243,000 4,561,000
Depreciation and amortization:    
Depreciation and amortization
Operating income (loss) 6,243,000 4,561,000
Corporate Segment [Member]    
Depreciation and amortization:    
Depreciation and amortization $ 409,000 $ 380,000